|Study Name||Study Title||Status||Recruit.||Contact|
A multicenter, randomized, 52-week, double-blind, parallelgroup,
|CASSIOPEIA (Hovon 131)||
Study of Daratumumab in combination with Bortezomib (VELCADE), Thalidomide, and Dexamethasone (VTD) in the first Line treatment of transplant eli...
|HOVON 103 AML||
A randomized phase II multicenter study with a safety run-in to assess the tolerability and efficacy of the addition...
|Hovon 132 AML||
Randomized study with a run-in dose-selection phase to assess the added value of
|HOVON 95 MM||
A randomized phase III study to compare Bortezomib, Melphalan, Prednisone (VMP) with High Dose Melphalan followed by...
This page provides the list of clinical studies currently registered in the LuxCLIN platform in the different therapeutic areas. By clicking on each study title, more information is displayed concerning the study objective and the participation conditions.